Displaying 2 results for

(More) Recent Shifts in HHS Leadership: June 2026 More Recent Shifts in HHS Leadership: June 2026 Catherine Murphy Get the latest updates on changes in leadership at CDC, FDA, HHS, and more in this Federal Health Policy Update. This provides updates to a previous Federal Health Policy Update: Recent HHS Leadership Changes That Impact Public Health. As Congress heads into a busy summer of work on FY27 appropriations, a potential reconciliation package, and looming midterm elections, the Trump Administration continues shaping HHS to the President’s Make America Healthy Again agenda. Since our last update in April, there have been a handful of new leadership shifts within HHS agencies. CDC Since the departure of Susan Monarez from her role as CDC Director in August 2025, the position has been covered by acting directors. In April, President Trump announced Erica Schwartz as his new pick for CDC Director. Schwartz brings experience as a physician in the U.S. Navy, as chief medical officer in the Coast Guard, and helped lead the government’s response to the COVID-19 pandemic as deputy surgeon general. The Senate HELP Committee has not yet noticed a hearing to review her nomination. Public response to her nomination, though, has been generally positive. In the same announcement, President Trump also highlighted his appointment of Jennifer Shuford as the CDC Deputy Director and Chief Medical Officer, and Sean Slovenski as CDC Deputy Director and Chief Operating Officer. Shuford, an ASTHO alumni member, is the former commissioner of the Texas Department of State Health Services and an infectious disease physician. Before her tenure as commissioner, she was the chief state epidemiologist. Slovenski brings a background as a health care executive and entrepreneur, with experience ranging from telehealth and wellness incentives, major companies and brands, and advocacy. Surgeon General The confirmation proceedings of President Trump’s previous pick for Surgeon General, Casey Means, stalled as senators deliberated on her statements on vaccine safety after her appearance before the Senate HELP Committee in February. At the end of April, the President announced his nomination of Nicole Saphier, a radiologist, director of breast imaging at Memorial Sloan Kettering Monmouth, and former medical contributor to the Fox News Channel. Saphier is viewed as a more mainstream nominee given that she is generally supportive of vaccines. Her priorities also include building trust in public health recommendations, combating chronic disease, and reducing ultra-processed foods. FDA In early May, it was announced that Commissioner Marty Makary would be leaving his role. Kyle Diamantas, formerly FDA’s Deputy Commissioner for Human Foods, has taken over as Acting Commissioner for the agency. Before joining FDA, Acting Commissioner Diamantas practiced law, focusing on food, drug, and life sciences regulatory matters. A nominee for FDA Commissioner has not yet been announced. Donald A. Prater has taken over as acting head of the Human Foods Program. ASPR In April, Sean Kaufman was announced as the White House nominee to lead ASPR as the Assistant Secretary for Preparedness and Response. He specializes in preventing spread of infectious disease and brings experience as a Senior Advisor for Global Affairs at CDC and, in previous roles, responded to infectious disease outbreaks including anthrax, SARS, and West Nile virus. HHS Additionally, Sara Brenner was announced as Senior Counselor for Public Health to Secretary Robert F. Kennedy, Jr. In her past roles, she served within FDA as Acting Commissioner and Principal Deputy Commissioner within the Office of the Commissioner. She is a preventive medicine and public health physician with extensive experience in federal health policy. In her broad federal experience, she has worked on COVID-19 response, within the White House Office of Science and Technology Policy, and worked on medical countermeasures and preparedness efforts. Leadership Promotes Trust in Public Health Minimizing leadership turnover bolsters stability in the public health continuum and allows for a more robust response to current and emerging public health threats. Ongoing changes within HHS can create uncertainty for the entire health ecosystem, from practitioners awaiting public health guidance to the broader public. In an environment where stability, clear communication, and transparency are needed, confirming leadership that promotes concise, well-researched advice will help continue efforts to rebuild trust in our governmental public health enterprise. These recently announced leaders bring a wealth of experience to their roles and have an opportunity to promote strong, evidence-based public health guidance for Americans. The Senate HELP Committee has not yet noticed confirmation hearings to review the nominations of the Senate-confirmed positions: the CDC Director, Surgeon General, and Assistant Secretary for Preparedness and Response are expected to be reviewed by the panel. ASTHO will continue to track updates to HHS leadership and confirmations. Reviewed by - Ekoma, Staley article yes

ASTHO Statement on Appointment of Texas Commissioner Jennifer Shuford, MD, MPH, as CDC Deputy Director ASTHO Statement on the Appointment of Jennifer Shuford as CDC Deputy Director ARLINGTON, VA — The Association of State and Territorial Health Officials (ASTHO) issued the following statement after the appointment of ASTHO board member and Texas Department of State Health Services Commissioner Jennifer Shuford, MD, MPH, as CDC deputy director and chief medical officer: “We applaud the appointment of Dr. Shuford to serve as deputy director and chief medical officer for CDC,” says ASTHO CEO Joseph Kanter, MD, MPH. “She is widely respected within the public health and governmental leadership communities. As the current commissioner of the Texas Department of State Health Services and a valued member of the ASTHO board of directors, Dr. Shuford has demonstrated exceptional leadership and a steadfast commitment to evidence-based public health. Her experience leading one of the nation’s largest and most complex state health agencies — particularly her work as a frontline infectious disease physician and chief state epidemiologist — makes her uniquely qualified to help lead CDC.” “Dr. Shuford understands the vital relationship between federal, state, local, territorial and tribal public health departments. We are confident that her clinical expertise and proven track record in crisis management and health promotion will be invaluable assets to CDC and the nation,” Kanter added. Dr. Shuford graduated from Colorado College in Colorado Springs with a bachelor’s degree in chemistry. She received her Doctor of Medicine degree from the University of Texas Southwestern Medical School. She completed an internal medicine residency at Presbyterian Hospital of Dallas, where she served as chief resident. Dr. Shuford completed an infectious disease fellowship at the Mayo Clinic in Rochester, Minnesota, and earned her Master of Public Health degree from the Harvard School of Public Health. Dr. Shuford serves on the faculty of the DSHS Preventive Medicine and Public Health Residency Program. She is a member of the Travis County Medical Society, the Texas Medical Association, and the Infectious Diseases Society of America. ASTHO Press Release Boilerplate website yes